Category: Company
-
We’re Headed to Closing The Gap 2025!
We’re thrilled to share that Control Bionics will be exhibiting and presenting at the 43rd Annual Closing The Gap Conference, taking place October 21–24, 2025 at the DoubleTree by Hilton in Bloomington, Minnesota. This event brings together the best minds in assistive technology, and we can’t wait to connect, learn, and share our latest innovations…
-
The ALS Association awards a prestigious Assistive Technology Grant to Control Bionics
Control Bionics is thrilled to announce it has been awarded one of the prestigious ALS Association 2023 Assistive Technology Grants. The ALS Association is the leading ALS organization in the world and is working to make ALS a livable disease while urgently searching for new treatments and a cure. The grant enables Control Bionics to amplify…
-
Myth V Fact Series #1
There are always myths that surround products in the technology world. Especially technology like the Neuro Node often finds itself surrounded by myths and misconceptions. In this blog series we will go through some of the myths we have heard about the Neuro Node and display facts of our products. Myth 1: The Neuro Node…
-
ASX Announcement: Appointment of CEO
Control Bionics Ltd (ASX: CBL) is pleased to announce the appointment of Jeremy Steele as Chief Executive Officer and a member of the board, effective from 19 January 2023.
-
Attending ASHA this month? Don’t miss this poster!
Don’t miss this poster at ASHA: Improving Traditional Eye Gaze Access to Augmentative and Alternative Communication (AAC) Devices. Learn more.
-
Annette Curry joins Control Bionics as Head of Sales – Australia
Control Bionics continues to expand our leadership team with new Head of Sales – Australia, Annette Curry. Annette brings years of experience as a nurse practitioner, sales and marketing leader.
-
Control Bionics Expands Management Team with Vice President – North America, Todd Tyler
Control Bionics is excited to announce the expansion of their management team with Vice President – North America, Todd Tyler.
-
Control Bionics Launches New Branding for Broadened Mission
We’re changing our look, but not our mission to become the world’s leading provider of innovative augmentative communication and control devices for people with speech and movement disabilities.
-
Popular Podcast, Fear and Greed, Spoke to Control Bionics on Their Sunday Feature
Control Bionics CEO Rob Wong sat down with the podcast Fear and Greed this week to discuss how Control Bionics helps patients with some of the most debilitating conditions to communicate.
-
Biotech Daily features Control Bionics in Dr. Boreham’s Crucible Article
As a regular contributor of Biotech Daily, which provides news on ASX-listed biotechnology companies, Dr. Boreham’s Crucible provides analysis of the biotech sector in Australia. Last week Control Bionics was featured in an article on the site.
-
Control Bionics (ASX:CBL) Looks to Solidify Global Presence
Rob Wong, CEO of Control Bionics, chats with Alan Kohler from Eureka Report to discuss the latest news from the newly ASX-listed business. ” … the fundamental point about that was that your brain sends very, very fast signals to muscles to act because that’s the fight or flight mechanism. Most of the outcomes that…
-
Control Bionics set to enter the ASX bourse next week; inspired by Stephen Hawking and already FDA approved
Medtech company Control Bionics (ASX:CBL) will list on the ASX next week. The company’s EMG (electromyography)-based technology helps people with disabilities inhibiting communications to do so through electronic devices that pick up their neuroelectric systems. Examples of such conditions include motor-neuron disease, cerebral palsy, and spinal cord injuries. Control Bionics’ flagship product, NeuroNode 3, is watch-sized…